Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy.
Gao J, Liang Y, Wang L. · 2022
Read Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy. by Gao J, Liang Y, Wang L. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9280632.txt.
Introduction
Gao and co-authors review how the states of tumor-associated macrophages shape cancer immunotherapy. Macrophages can polarize into M1 forms that fight tumors or M2 forms that help them. In tumors, the M2-like form dominates and aids vessel growth, immune suppression, and spread. That makes these cells a hot target for new treatments.
The review first explains polarization and its effects in the tumor setting. It then covers how M2-like cells blunt checkpoint blockade and CAR-T cell therapy. Signaling paths that set macrophage state are mapped next. The authors discuss ways to flip cells back to the M1 state. Turning tumor helpers into tumor fighters is the central hope.
Catalog record
| CREATOR | Gao J, Liang Y, Wang L. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy By Jing Gao, Yuanzheng Liang, Liang Wang Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2022.888713 ABSTRACT Abstract Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed. Keywords: tumor-associated macrophages, polarization, tumor microenvironment, signaling pathways, cancer therapy 1 INTRODUCTION Macrophages are an important part of the mononuclear phagocytic system and are involved in immune system regulation, pathogen clearance, wound healing, and angiogenesis. Furthermore, there is a close relationship between macrophages and tumors. Under the stimulation of various cytokines, macrophages can be polarized into two forms that exhibit different functions: M1 macrophages, which are pro-inflammatory and tumor-inhibiting, and M2 macrophages, which are anti-inflammatory and tumor-supporting. Therefore, macrophages that infiltrate the tumor microenvironment (TME), also known as tumor-associated macrophages (TAMs), have gradually attracted attention. TAMs are generally M2-like anti-inflammatory immune cells and are associated with malignant disease progression, drug resistance, and poor prognosis. Current cancer treatment strategies are not limited to traditional radiotherapy, chemotherapy, or surgical resection as cancer treatment has entered the era of targeted therapy and immunotherapy. Modulation of TAMs by regulating M1 signaling activation has emerged as a promising and novel immunotherapy strategy. Hence, understanding the role of signaling pathways associated with TAM polarization and approaches that can regulate TAM repolarization provide a new perspective for cancer therapy. 2 POLARIZATION OF TAMS AND THEIR ROLE IN THE TME TAMs are a specific group of macrophages that reside in the TME. Stimulated by different factors, these macrophages exhibit different phenotypes and functions, through a process termed as TAM polarization. Understanding the cellular and molecular mechanisms associated with TAM polarization in the TME contributes to a deeper insight into tumor pathogenesis and can provide new insights for cancer therapy. In this section, we focus on TAM polarization and their role in the TME. 2.1 Differentiation of Macrophages Macrophages are involved in host defense, wound healing, and immune regulation and differentiate into different phenotypes in response to environmental cues (1). Due to the plasticity of macrophages, undifferentiated macrophages (M0) can be polarized into two types: classically activated macrophages (M1) and alternatively activated macrophages (M2) (2). M1 macrophages, which are stimulated by interferon (IFN)-γ (produced by T-helper 1 cells) and bacterial lipopolysaccharide, are generally considered to have pro-inflammatory and anti-tumor effects and express inflammatory factors including interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α. In contrast, M2 macrophages, which are stimulated by IL-4 and IL-13 (produced by T-helper 2 cells), play a critical role in tumor initiation, proliferation, metastasis, and immune evasion, and express anti-inflammatory elements, such as IL-10 and transforming growth factor (TGF)-β (3, 4). It is worth noting that macrophages are a heterogeneous group of immune cells and are not just classified into M1 and M2 macrophages. Mantovani et al. further classified activated M2 macrophages into M2a, M2b, and M2c macrophages, which are stimulated by IL-4/IL-13, immune complexes and lipopolysaccharide/IL-1 receptor, and IL-10, respectively (5). M2a and M2b macrophages play an immunomodulatory role and promote T-helper 2 cell response, whereas M2c macrophages are associated with immune response suppression and tissue remodeling. Additionally, the concept of M2d macrophages (also at times termed as TAMs) that are activated by Toll-like receptors and specifically express vascular endothelial growth factor (VEGF) and IL-10 was proposed (2, 4). Functionally, M2d macrophages participate in angiogenesis and tumor progression. Different inducers, surface markers, and cytokine products are shown in Figure 1. Given that the differential activation of macrophages can promote or inhibit inflammation as well as regulate tumor proliferation, targeting TAMs in the TME is receiving increasing attention. [Figure: The direction of macrophage differentiation in response to different environmental cues. IC, immune complex; LPS, lipopolysaccharide; TLR, Toll-like receptor; VEGF, vascular endothelial growth factor; MR, mannose receptor; Arg 1, arginase 1.] 2.2 TME and TAM Polarization The TME is a highly complex and critical environment that is encased on the outside by collagen and elastin fibers and is composed of blood vessels, cancer cells, stromal cells, and immune cells, such as T cells, B cells, dendritic cells, myeloid-derived suppressor cells, and macrophages (6). The network formed by these elements participates in the recruitment of tumor and immune cells, constructing a tumorigenic environment that promotes drug resistance. Thus far, various mechanisms and pathways involved in immune modulation, angiogenesis, and metastasis have been studied to gain a deeper understanding of the interactions between these components in the TME. For example, cytokines in the TME, such as TNF-α, IL-6, and IL-8, are associated with angiogenesis and tumor metastasis, whereas IL-4, IL-13, and IL-10 are associated with immune response suppression. Moreover, various signaling pathways associated with macrophage polarization, including nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription 1 (STAT1), are also relevant to the TME and are discussed below (5). In this context, identifying and targeting immunosuppressive elements in the TME may shed light on the mechanisms underlying tumor generation and development. TAMs are one of the most common immune cells that infiltrate the TME. These cells originate from two main sources: bone marrow peripheral monocytes and embryos that reside in different tissues, the latter including Kupffer cells in the liver, alveolar macrophages in the lungs, microglia in the brain, and osteoclasts in the bone (7). Peripheral blood circulating monocytes, which are recruited into the TME by circulating tumor-secreting factors and transform into macrophages, are generally thought to be the main source of TAMs. In contrast, a small number of macrophages are derived from early tissue-resident macrophages originating in the yolk sac or fetal liver (8). Broadly speaking, monocytes are attracted by cytokines, such as colony stimulating factor (CSF)-1 and CCL-2, and subsequently polarize into TAMs in the TME. These polarized TAMs usually express M2 macrophage markers and cytokines, such as mannose receptors (CD206), scavenger receptor (CD163), VEGF, and IL-10, and exhibit tumor-supporting effects, and are hence called M2-like TAMs. Conversely, few TAMs in the TME express CD86 and CD80 markers and are termed as M1-like TAMs, and typically exhibit anti-tumor effects (9). 2.3 Role of M1-Like TAMs in the TME The role of M1-like macrophages in the TME is mainly pro-inflammatory and they inhibit tumor progression. Most studies have focused on M2-like macrophages, which play a pro-tumor role and constitute the predominant class of TAMs. However, some researchers have suggested that the role of M1-like TAMs in tumors is bidirectional. It has been demonstrated that CD68+ HLA-DR+ M1-like TAMs enhance the motility of tumor cells in hepatocellular carcinoma. Additionally,